Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay.
Apical membrane antigen 1 (AMA1) is one of the best-studied blood-stage malaria vaccine candidates. When an AMA1 vaccine was tested in a malaria naïve population, it induced functionally active antibodies judged by Growth Inhibition Assay (GIA). However, the same vaccine failed to induce higher grow...
Main Authors: | Kazutoyo Miura, Suwani Perera, Sarah Brockley, Hong Zhou, Joan A Aebig, Samuel E Moretz, Louis H Miller, Ogobara K Doumbo, Issaka Sagara, Alassane Dicko, Ruth D Ellis, Carole A Long |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3113848?pdf=render |
Similar Items
-
Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children.
by: Alassane Dicko, et al.
Published: (2008-02-01) -
Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians.
by: Alassane Dicko, et al.
Published: (2007-10-01) -
IgGs from Human Milk Hydrolyze microRNAs
by: Ivan Yu. Kompaneets, et al.
Published: (2020-05-01) -
Anticorps monoclonaux anti-IgGs de zébu. Réactivités comparatives
by: C. Atrax, et al.
Published: (1998-01-01) -
Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers
by: Andrew McKeon, et al.
Published: (2021-02-01)